The DEINOL collaborative programme, aimed at 2G bioethanol production, continues with the ABENGOA group and the continuous support of Bpifrance;
By signing this collaborative agreement, DEINOVE provides the means of rapid and global industrialisation of its process.
DEINOVE (Alternext Paris: ALDEI), a cleantech company that designs and develops a new generation of industrial processes based on the exploitation of Deinococcus bacteria, announces the signing of a collaboration agreement with ABENGOA, one of the world’s leading bioethanol producer, with the support of Bpifrance.
The Agreement is concluded for up to 36 months and focuses on the development with its industrial partner of DEINOVE's consolidated bioprocess (CBP) using Deinococcus bacterium selected by DEINOVE to digest and convert agricultural residues to ethanol at a competitive cost. Performances obtained with substrates supplied to DEINOVE by ABENGOA will be evaluated in order to set up a process that can be implemented, subject to adequate performance, in full-size factories.
TEREOS has supported the DEINOL project since 2010 and is also a DEINOVE shareholder. Considering the development of food production at its BENP Lillebonne plant, TEREOS waived its option on the DEINOL project. DEINOVE welcomes, in agreement with TEREOS and Bpifrance, ABENGOA as the new industrial partner of the DEINOL project.
In January 2014 DEINOVE announced a 9% ethanol production, using Deinococcus bacteria, which demonstrates the technological and potential economic viability of its production process.
DEINOL, a collaborative research programme for the development of second-generation biofuel production processes based on the extraordinary capacity of Deinococcus bacteria, obtained in 2010 a funding commitment from Oseo-ISI (now Bpifrance) for €8.9 million, including €6 million for DEINOVE. The company has already received €4m and achieved the first key milestones. The DEINOL consortium will receive additional funding from Bpifrance upon reaching successful milestones.
As stated when releasing its 2013 financial results, DEINOVE believes it is capable of receiving licensing revenues as of 2016.